Heck Capital Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-439
Closed -$83.6K 102
2018
Q3
$83.6K Sell
439
-29
-6% -$5.33K 0.03% 93
2018
Q2
$78K Buy
468
+4
+0.9% +$642 0.03% 94
2018
Q1
$78.1K Sell
464
-8
-2% -$1.34K 0.03% 82
2017
Q4
$77.2K Buy
472
+6
+1% +$1.08K 0.04% 77
2017
Q3
$95.5K Buy
466
+17
+4% +$3.95K 0.05% 77
2017
Q2
$109K Sell
449
-35
-7% -$8.22K 0.06% 69
2017
Q1
$116K Sell
484
-20
-4% -$4.66K 0.07% 61
2016
Q4
$106K Buy
+504
New +$104K 0.08% 59

Other funds holding AGN

Heck Capital Advisors's AGN Position: Q4 2018 in Review

Heck Capital Advisors sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 439 shares — an estimated $83.6K sold.

Heck Capital Advisors first reported a position in AGN in Q4 2016 and held it in 8 quarters. The position peaked at $116K in Q1 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Heck Capital Advisors reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Heck Capital Advisors sold 439 Allergan plc shares in Q4 2018, an estimated $83.6K.
  • Heck Capital Advisors first reported a position in Allergan plc in Q4 2016 and held it in 8 quarters.
  • Heck Capital Advisors's Allergan plc position peaked at $116K in Q1 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Heck Capital Advisors's 13F filing for Q4 2018, filed 19 May 2025.